切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Reverse Transcriptases - Quinone reductase - Tankyrases - CREBBP

10 件产品

每页
清除全部
  1. Etravirine (TMC125)
    B2224 Etravirine (TMC125)
    中文名: 依曲韦林
    Target: Reverse Transcriptases
    Summary: 逆转录酶抑制剂
      ≥19.35 mg/mL
      insoluble in H2O
  2. Zalcitabine
    B2223 Zalcitabine
    中文名: 扎西他滨
    Target: Reverse Transcriptases
    Summary: 逆转录酶抑制剂
      ≥10.65 mg/mL
      ≥15.87 mg/mL
  3. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: 端锚聚合酶抑制剂
      ≥22.45 mg/mL
      insoluble in H2O
  4. Dapivirine (TMC120)
    A8554 Dapivirine (TMC120)
    中文名: 达匹维林
    Target: Reverse Transcriptases
    Summary: 非核苷逆转录酶抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  5. Emtricitabine
    A8422 Emtricitabine
     1 Citation
    中文名: 恩曲他滨
    Target: Reverse Transcriptases
    Summary: 逆转录酶抑制剂
      ≥10.4 mg/mL
      ≥50.1 mg/mL
  6. Didanosine
    A8410 Didanosine
    中文名: 去羟肌苷
    Target: Reverse Transcriptases
    Summary: 逆转录酶抑制剂
      ≥23.61 mg/mL
      insoluble in H2O
  7. Tenofovir Disoproxil Fumarate
    A1755 Tenofovir Disoproxil Fumarate
    中文名: 富马酸替诺福韦酯
    Target: Reverse Transcriptases
    Summary: 抗逆转录制剂(HIV-1 RT 抑制剂)
      ≥31.78 mg/mL
      ≥2.615 mg/mL
  8. SGC-CBP30
    A4491 SGC-CBP30
     2 Citation
    Target: CREBBP|EP300
    Summary: CREBBP/EP300 bromodomain抑制剂
      ≥20.05 mg/mL
      ≥4.67 mg/mL
  9. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain抑制剂
      ≥49.6 mg/mL
      insoluble in H2O
  10. Resveratrol
    A4182 Resveratrol
     2 Citation
    中文名: 白藜芦醇
    Target: Sir2-like Family Deacetylases (Sirtuins)|COX|LOX|Adenylyl cyclase|Quinone reductase
    Summary: SIRT1激活剂
      ≥9.65 mg/mL
      insoluble in H2O

10 件产品

每页